GOLDMAN SACHS GROUP INC - BRIACELL THERAPEUTICS CORP ownership

BRIACELL THERAPEUTICS CORP's ticker is BCTX and the CUSIP is 10778Y302. A total of 22 filers reported holding BRIACELL THERAPEUTICS CORP in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of BRIACELL THERAPEUTICS CORP
ValueSharesWeighting
Q1 2023$701,790
+1089.5%
94,200
+748.0%
0.00%
Q2 2021$59,00011,1080.00%
Other shareholders
BRIACELL THERAPEUTICS CORP shareholders Q3 2021
NameSharesValueWeighting ↓
Lynwood Capital Management Inc. 1,198,000$6,733,0007.35%
K.J. Harrison & Partners Inc 479,838$2,748,0000.97%
SABBY MANAGEMENT, LLC 94,005$528,0000.67%
Redmond Asset Management, LLC 137,689$774,0000.29%
Concord Wealth Partners 17,775$100,0000.03%
Virtu Financial LLC 48,347$272,0000.02%
Caption Management, LLC 177,000$996,0000.01%
WASATCH ADVISORS LP 353,744$1,988,0000.01%
Summit Trail Advisors, LLC 35,000$197,0000.01%
BLUEFIN CAPITAL MANAGEMENT, LLC 17,546$99,0000.01%
View complete list of BRIACELL THERAPEUTICS CORP shareholders